Blog Read the latest perspectives from our team of subject matter experts and others The Trust Fall: Building Successful & Diverse Trials Outside the U.S.As the U.S. ramps up for release of the latest COVID-19 vaccine booster, the Centers for Disease Control and Prevention (CDC) recommends that all Americans aged 6 months and… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Diversity & Inclusion Drug Development KOL Engagement Medical Devices Provider Data Research Post Industries:Commercialization Medical Devices Payors Pharmaceutical & Biotechnology Provider Data Research KOL EngagementNavigating HCP Digital Engagement: Best PracticesAs medical education evolves, the need for effective digital engagement strategies is also growing. In order to ensure that healthcare professionals (HCPs) have access to the most up-to-date information… Continue reading → Read the articleno Diversity & InclusionDrug DevelopmentKOL EngagementBuilding an Exclusive Strategy with Inclusive HCPsAs healthcare providers (HCPs) are increasingly relying on evidence-based data and clinical guidelines, life science organizations must shift their focus to enabling HCPs in the effective adoption of these medicines.… Continue reading → Read the articleno KOL EngagementLet’s Get Personal: Four Benefits to Omnichannel StrategiesWith the proliferation of digital media, marketing in the healthcare industry has shifted from traditional tactics to an omnichannel approach. Omnichannel engagement for physician marketing is a powerful tool… Continue reading → Read the articleno KOL EngagementNurses: The Unsung Heroes in Pharma and Biotech for Health Equity and Medication AdherenceHealthcare providers are often the first line of defense in ensuring that people receive the medical treatment they need. But nurses are often overlooked as a solution to addressing health… Continue reading → Read the articleno Diversity & InclusionKOL EngagementFour Ideas for Pharma to Maximize the Influence of Digital Opinion Leaders in MedicinePharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education. With the rise… Continue reading → Read the articleno KOL EngagementThree Ways Field Medical Teams Can Close Care Gaps and Increase Scientific Share of VoiceAs the primary interface between healthcare providers (HCPs) and pharmaceutical companies, medical science liaisons (MSLs) have a unique opportunity to engage with HCPs in clinical discussions and bridge care gaps… Continue reading → Read the articleno CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementMedical DevicesProvider DataResearchH1 Honored with a Spot on Y Combinator’s 2023 Best Companies List and Slice of Healthcare’s Inaugural Digital Health Leaders ListH1, the connecting force for global healthcare provider, clinical, science, and research information, today announced that it has been recognized in two prestigious annual lists: Y Combinator’s 2023 Best Companies… Continue reading → Read the articleno CommercializationKOL EngagementMedical Public Awareness Campaigns—Examples and EffectivenessMedical public awareness campaigns are designed to distribute important healthcare messages to large populations. With over seven billion people in the world, it is necessary to find ways to share… Continue reading → Read the article KOL EngagementTis the Season…for Conference PlanningAs we come out of the holidays , in the United States, some of the greatest minds in medicine and healthcare are gathered this week at the JP Morgan Healthcare… Continue reading → Read the articleno CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementMedical DevicesProvider DataResearchNew Look, Same Commitment!I’m excited to officially unveil the new branding and website our team has been working on for several months. This new branding comes with much thought and consideration, and reflects… Continue reading → Read the articleno Artificial IntelligenceKOL EngagementAI and the MSL Evolution: What Time Has Taught UsI recently had the chance to deliver the keynote address at the 2022 MSL Society Conference in Las Vegas. It’s been a transformative year for pharma and life sciences, specifically… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementMedical DevicesProvider DataResearchTimmy Awards Announces H1 as 2022 Tech for Good FinalistThe 8th Annual Timmy Awards run by Tech in Motion celebrates leaders in tech, recognizing the top workplaces for tech professionals across North America. We are thrilled to announce that H1 is… Continue reading → Read the article KOL EngagementGoing with the Digital FlowEven now: two and a half years later, the COVID-19 pandemic continues to have a substantial impact on the activities of Medical Science Liaisons (MSLs), including access to Key… Continue reading → Read the article Diversity & InclusionDrug DevelopmentKOL EngagementA New Reflection on Pharma, Research, and Patient CarePharma has long existed in elevated, prestigious academic institutions: ivory towers of reputable and revered centers of excellence famous for disseminating the latest in clinical research and medical breakthroughs.… Continue reading → Read the article Drug DevelopmentKOL EngagementH1 Announces Partnership with Society for Clinical Research SitesThe Society for Clinical Research Sites (SCRS) announced today that H1, a pioneer in creating connected ecosystems where data, people, research, and clinical trial intelligence come together to drive the… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchThe Evolution of H1’s Core ValuesI remember it clearly. Me, Ian – our co-founder and a handful of brave individuals who would become the first H1 employees, sitting around a table writing down the values… Continue reading → Read the article KOL EngagementA Case Study on Global KOL EngagementIn a recent issue of Nature that traced the origins of key opinion leaders in pharma back to a Pfizer launch in the mid-1950s, the article tracked the evolution and… Continue reading → Read the article KOL EngagementReuters Pharma and MAPS 2022 Event Wrap-UpEvents are back in person and there’s a buzz in the air. Stacey Rivkin, H1’s VP of Client Strategy & Solutions just got back from the 2022 Medical Affairs… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchH1 Recognized as One of Forbes’ Best Startup Employers 2022H1, which provides the largest global healthcare professional data ecosystem to enable life sciences, academic medical institutions, health systems, and payers, today announced it has been included on Forbes’… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchH1 Named to NYC Digital Health 100 by NYCHBLH1, which provides the largest global healthcare platform that connects healthcare professionals, today announced that New York City Health Business Leaders (NYCHBL), the organization that serves as the gateway to… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchH1 Wraps Up 2021 with Gratitude2021 was a year of enormous change around the world, as we learn to live and work in new ways. For H1, it was also a year of enormous growth,… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchCo-Founder and CEO of H1 Named to Forbes 30 Under 30H1 announced today that its CEO and Co-Founder Ariel Katz was named to the prestigious Forbes 30 under 30 list. Ariel started his first company in college, ResearchConnection, to help… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchZiad Ismail Joins H1 During Period of High GrowthH1, which provides the largest global healthcare network that connects healthcare professionals, announced today that it has added Ziad Ismail to the management team as Chief Operating Officer. Ziad… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchH1 Raises Series CToday we announced our Series C of $100 million led by Altimeter and participation from new investors including Goldman Sachs Asset Management and Flex Capital. It also includes the support… Continue reading → Read the article KOL EngagementHow Physicians Are Compensated by Life Sciences CompaniesIt’s no secret that compensation for physicians consulting at pharmaceutical, device and life sciences firms is often much higher than what’s on the table at hospitals and university-affiliated medical centers.… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchFormer Dropbox CIO Joins Board of Healthcare Data Startup H1Board member Sylvie Veilleux (Salesforce, Dropbox), CFO Karen Moran (Alteryx, Domo) and CDO Mayur Thakur (Goldman Sachs, Google) bring decades of experience and add bench strength as H1 expands.… Continue reading → Read the article KOL EngagementWhy Physicians May Want to Become Key Opinion LeadersDuring drug development, life science companies often turn to healthcare professionals (HCPs) for input, advice and expertise. These HCPs advising companies are generally known as Key Opinion Leaders (KOLs), thought… Continue reading → Read the article KOL EngagementEducating Physicians to Improve the Patient Diagnostic JourneyThe best diagnostic journey for a patient is the shortest. The less time is lost between a patient seeing a healthcare provider for the first time for their symptoms… Continue reading → Read the articleno KOL EngagementDr. Sekar Kathiresan’s Impact on CardiologyScholarly Influence Publications Dr. Kathiresan is a cardiologist and the CEO of Verve Therapeutics, a company that works on gene editing medicine for cardiovascular disease. Additionally, he is… Continue reading → Read the article KOL EngagementThe Term KOL: Keep It or Ditch It?Listening to webinars and reading reports about the latest trends and developments in medical affairs is one of the things we do incessantly at H1 – after all we need… Continue reading → Read the article KOL EngagementThe Power of Micro-Influencers in HealthcareHow can we break through the noise to reach healthcare providers and key opinion leaders with important information? Consistently engaging external experts has always been one of the main… Continue reading → Read the article KOL EngagementDr. Krishna Aragam’s Impact on CardiologyScholarly Influence Publications Dr. Aragam is a Rising Star and Preventive Cardiologist at Massachusetts General Hospital as well as an Instructor of Medicine at Harvard Medical School. According to… Continue reading → Read the article KOL EngagementHow to Engage the Payer CommunityEven before COVID threw the entire healthcare ecosystem into disarray, payers as well as the healthcare market in general faced significant cost pressure. Healthcare payers reacted with consolidation and vertical… Continue reading → Read the article KOL EngagementKey Opinion Leader: Dr. Naveed Sattar’s ImpactScholarly Influence Publications Dr. Naveed Sattar is a top healthcare professional specializing in Endocrinology, Diabetes & Metabolism, and Cardiovascular Disease. He is renowned for his work in diabetes.… Continue reading → Read the article KOL EngagementKey Opinion Leader: Dr. Hugh Sampson’s ImpactPublications Scholarly Influence Dr. Hugh Sampson is an esteemed healthcare professional with a specialty in pediatric allergy and immunology. He is the Kurt Hirschhorn Professor of Pediatrics at the… Continue reading → Read the article Drug DevelopmentKOL Engagement9 Ways Medical Affairs Can Use Claims and Referral DataIn a recent interview an experienced medical affairs professional reminisced about the days when key opinion leader selection was a difficult and time consuming activity, which often relied on established… Continue reading → Read the article KOL EngagementProvider DataConnecting the Dots between Patients, Physicians and PayorsSuccessful engagement of external experts ranks very high on the list of challenges medical affairs professionals face. No surprise here, building relationships that support long-term engagement is hard under… Continue reading → Read the article KOL EngagementKey Opinion Leader: Dr. Morie Gertz’s Impact on Hematology & OncologyPublications Scholarly Influence Dr. Morie Gertz is a leading healthcare professional whose specialty is oncology and hematology. Dr. Gertz works at the Mayo Clinic in Minnesota and is the… Continue reading → Read the article KOL EngagementHelpful Hints for MSLsBeginning a new job is exciting, even though new jobs often come with new obstacles and potential challenges. Through the duration of the application process, the prospect of being a… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchH1 Closes $58 Million Series B FundingToday, H1 announced a $58 million Series B round of funding to continue working towards our mission of creating a healthier future by connecting parties in the healthcare ecosystem.… Continue reading → Read the article KOL EngagementComplying with MSL RegulationsMedical Science Liaisons (MSLs) are members of the Medical Affairs departments in pharmaceutical companies and have a wide range of responsibilities. An important part of the MSL role is… Continue reading → Read the article KOL EngagementMSL Conduct Dos and Don’tsMedical Science Liaisons (MSLs) are in the field (almost) every day and so are their field-based commercial colleagues, specifically sales representatives. Although they interact with the same people, healthcare… Continue reading → Read the article KOL EngagementPayor Mix: Understanding How Patients Receive Care and Who Pays for itTo find out which healthcare providers (HCPs) are actively treating patients in a therapeutic area, you’ll want access to more than just publication information. To really dig in, you… Continue reading → Read the article KOL EngagementAnnouncing A New Way to Identify KOLs with Claims DataPublications can only get you so far. If your medical affairs team really wants to know who’s actively treating patients in a therapeutic area, you need access to claims data.… Continue reading → Read the article KOL EngagementThe Importance of an Integrated KOL Engagement StrategyBuilding long-term, mutually beneficial relationships with external stakeholders such as physicians, key opinion leaders (KOLs) and other experts is the ultimate goal of medical affairs, specifically medical science liaisons (MSLs).… Continue reading → Read the article CommercializationKOL EngagementFor-profit vs. Nonprofit Hospitals: Pros & ConsAs of 2017, about 59 percent of all hospitals registered in the U.S. were nonprofit, and 21.3 percent were for-profit hospitals, with the remainder state-owned. With nonprofit hospitals outnumbering for-profit hospitals… Continue reading → Read the article CommercializationKOL EngagementMedical DevicesWhat’s the Top Integrated Delivery Network in Your Area? Largest IDNs by RegionIntegrated delivery networks (IDNs) offer both health care services and health insurance plans. That simple definition, however, doesn’t do justice to the impact IDN healthcare has had on the industry.… Continue reading → Read the article KOL EngagementPhysician Referrals: How Do Doctors Make their Decisions?Almost every patient will, at some point, require a physician referral, typically from a primary care doctor. Much of the time, patients aren’t provided options. Referrals are made based on… Continue reading → Read the article CommercializationKOL EngagementAcute Care Hospitals & Their Role in HealthcareAs the world’s population continues to age, the demand for acute care hospitals will only increase. According to the latest Centers for Medicare and Medicaid Services (CMS) Hospital Compare List, there… Continue reading → Read the article CommercializationKOL EngagementWhat is a Hospital Purchasing Agent?Any partner to the healthcare industry knows there are often many decision-makers in the buying process. Often one of the most pivotal roles in that of a hospital purchasing agent.… Continue reading → Read the article CommercializationKOL EngagementMedical Capital Equipment Sales InsightsA common budget category for hospitals, surgical centers, and outpatient care facilities is capital equipment. Capital equipment purchases can cover a broad range of machines. For example, capital equipment can include… Continue reading → Read the article KOL Engagement5 Daily Challenges of MSLsThe job of an MSL is not for the faint of heart: an exciting job for scientists or medical doctors, being an MSL is not without a set of challenges.… Continue reading → Read the article Drug DevelopmentKOL EngagementThe Future of Medical AffairsIt is not the first time we say this: healthcare is rapidly changing and is driven by several different factors, chief among them our ability to create ever-increasing amounts… Continue reading → Read the article CommercializationKOL EngagementSunshine Act Reporting & Compliance: What You Need to KnowWith the ultimate goal of transparency, the U.S. enacted the Physician Payments Sunshine Act to shed light on financial relationships between medical device, supply, biologic, and pharmaceutical manufacturers and physicians. The… Continue reading → Read the article KOL EngagementHealth Outcomes Liaison – Managing Relationships with PayorsThe job of a Medical Science Liaison (MSL) comes with an amazing variety of responsibilities. In addition, to building and maintaining relationships with key opinion leaders, MSLs are increasingly tasked… Continue reading → Read the article KOL EngagementA Rare Species: The Medical Device KOLWhen writing about key opinion leaders (KOLs) in the healthcare industry we focus almost exclusively on how the pharmaceutical industry relies on these clinical and scientific thought leaders and experts.… Continue reading → Read the article Drug DevelopmentKOL EngagementClinical Trial Enrollment ChallengesWe talk a lot about Medical Science Liaisons (MSLs) and Key Opinion Leaders (KOLs) and their roles and responsibilities. We also dedicated a blog to the emerging role of… Continue reading → Read the article KOL EngagementThe Typical Medical Science LiaisonWe have been writing about Medical Science Liaisons, their jobs, responsibilities, typical job descriptions, scientific background, challenges – regulatory and otherwise – and rewards, about the key opinion leaders (KOLs)… Continue reading → Read the article Artificial IntelligenceKOL Engagement5 Ways Artificial Intelligence Will Benefit Medical Science LiaisonsBy now, pretty much everybody agrees that artificial intelligence (AI) will change all of our lives forever. From transportation to quality control, from education to medicine, from entertainment to manufacturing,… Continue reading → Read the article KOL EngagementWhich Types of Skills Are Most Valuable to MSLsMedical Science Liaisons (MSL) are science subject matter experts first and foremost. They educate physicians about their drugs, the underlying science, and details of clinical studies. In addition, they… Continue reading → Read the article CommercializationKOL EngagementFact & Fiction About Medical Sales Training ProgramsIf you run a sales team, then you are all too familiar with the pressures of ensuring each sales executive is well-trained and equipped with the tools needed to their… Continue reading → Read the article CommercializationKOL EngagementWhat Is an IDN & What Role Does It Play in Healthcare?Integrated delivery networks (IDNs) have carved out a place for themselves in the healthcare industry. An IDN (in the recent past also called integrated health network [IHN] or multihospital system… Continue reading → Read the article CommercializationKOL EngagementMedical DevicesHow to Find Doctors’ Email Addresses for FreeIf a physician’s phone system and receptionist are good at their jobs, you probably aren’t getting through to that prospect with a cold call. And although you may be able… Continue reading → Read the article KOL EngagementThe Importance of KOLsMuch is written about the importance of key opinion leaders (KOLs) for the pharmaceutical industry. These independent medical and scientific experts advise pharma companies on a broad range of activities,… Continue reading → Read the article KOL EngagementKOL Presentations Go DigitalWe live in an increasingly digital world and key opinion leaders (KOLs) are no exception. Though face-to-face meetings and presentations are still the preferred way for KOLs to interact with… Continue reading → Read the article Drug DevelopmentKOL EngagementThe Roles of KOLs in the Drug Development ProcessKey opinion leaders (KOLs) play an important role throughout the entire drug development and approval process. Most companies work with KOLs during Phases IIIa and IIIb as well as during… Continue reading → Read the article CommercializationKOL EngagementWhat Are GPOs & What Role Do They Play?Many hospitals, healthcare systems, and other healthcare providers use group purchasing organizations (GPOs) to control costs and improve efficiency in medical supply purchases. For MedTech companies and vendors on the… Continue reading → Read the article KOL EngagementOpinion Leader Identification: Big Data to KOL Short ListFor a pharmaceutical company, the decision to work with a certain key opinion leader (KOL) is very important. Engaging the right KOL is critical in establishing credibility among physicians for… Continue reading → Read the article KOL EngagementThe Science of Building and Maintaining a KOL DatabaseA lot has been written about KOLs and the value they can bring not only to drug development and commercialization in the pharmaceutical industry but also to companies developing medical… Continue reading → Read the article KOL EngagementThe Challenge of Performance Review for Medical Science LiaisonsThe daily responsibilities of a Medical Science Liaison (MSL) are varied and broad but a common denominator is their central role in interacting with, informing, and educating stakeholders in… Continue reading → Read the article
